Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Atomwise uses an AI-powered superplatform to explore chemical space and identify novel, drug-like small molecules. The platform supports programs aimed at delivering first- and best-in-class candidates, with a focus on immune and inflammatory diseases. A world-class team of scientists and engineers is redefining how small-molecule drugs are discovered.
Sources
drugpatentwatch.com shapes more of what AI says about Atomwise than any other source, at 23% of its citations.
consainsights.com · intuitionlabs.ai · mauriziochirivainternati.com · ardigen.com
The market map
Biopharma Research Platforms and Services →Where AI ranks Atomwise
Excerpts where Atomwise appeared in the AI's answer
Atomwise : Uses deep learning architectures like AtomNet to conduct structure-based virtual screening across massive libraries of billions of compounds, predicting bioactivity and ranking candidate molecules.
Atomwise — uses AI-based virtual screening to identify promising molecules from large libraries.
Excerpts where Atomwise appeared in the AI's answer
Atomwise (AtomNet) : Utilizes deep convolutional neural networks tailored for structure-based virtual screening and bioactivity prediction
Atomwise (AtomNet) : A pioneer in structure-based deep convolutional neural networks
Excerpts where Atomwise appeared in the AI's answer
Atomwise : Uses deep convolutional neural networks to predict the binding affinity of small molecules to protein targets
Excerpts where Atomwise appeared in the AI's answer
Atomwise (AtomNet): Utilizes structure-based, convolutional neural networks
